Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Toronto Stock Exchange  >  Cardiome Pharma Corp    COM   CA14159U3010

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
02/01/2016 02/02/2016 02/03/2016 02/05/2016 02/08/2016 Date
9.11 8.95 8 7.79 7.53 Last
611 300 3500 1200 1115 Volume
-1.51% -1.76% -10.61% -2.63% -3.34% Change
Financials ( CAD)
Sales 2015 34,9 M
EBIT 2015 -23,5 M
Net income 2015 -22,9 M
Debt 2015 -
Yield 2015 -
Sales 2016 48,4 M
EBIT 2016 -17,9 M
Net income 2016 -14,1 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 -
P/E ratio 2016
Capi. / Sales 2015 4,25x
Capi. / Sales 2016 3,06x
Capitalization 148 M
More Financials
Company
Cardiome Pharma Corp. is a specialty pharmaceutical company, which engages in the discovery, development and commercialization of cardiovascular therapies that will improve the health of patients suffering from heart disease.Cardiome has two marketed, in-hospital, cardiology products, BRINAVESS,... 
Sector
Pharmaceuticals
Calendar
02/11 | 02:40pmPresentation
More about the company
Surperformance© ratings of Cardiome Pharma Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on CARDIOME PHARMA CORP
01/27 CARDIOME PHARMA : Announces Filing of Orphan Drug Application for Oral Vernakala..
01/21 CARDIOME PHARMA : Announces the Launch of ESMOCARD LYO in Belgium
01/13 CARDIOME PHARMA : announces filing of marketing authorization application for in..
01/12 CARDIOME PHARMA : Announces Share Purchase Agreement with Lincoln Park Capital F..
01/06 CARDIOME PHARMA : and SteadyMed Announce Decision for Centralized Review of Trev..
01/05 CARDIOME PHARMA : Enters Commercialization Agreement with Chong Kun Dang for BRI..
2015 CARDIOME PHARMA : Files New Drug Submission Seeking Canadian Approval of intrave..
2015 CARDIOME PHARMA : Reports Third Quarter 2015 Financial Results
More news
Sector news : Biopharmaceuticals
08:46a JAZZ PHARMACEUTICALS : Results from Phase 3 Trial of Defibrotide for the Treatme..
08:07a SANOFI : Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at C..
07:56aDJRegeneron Reports Slowing Sales Growth for Key Eye Drug
More sector news : Biopharmaceuticals
News from SeekingAlpha
01/12 Cardiome inks $20M share purchase deal with Lincoln Park Capital
01/06 EMA to review Cardiome's Trevyent MAA under streamlined centralized procedure
2015 PREMARKET BIOTECH DIGEST : Harvoni's Label Expansion, AstraZeneca's Tagrisso App..
2015 Cardiome Pharma's (CRME) CEO William Hunter on Q3 2015 Results - Earnings Cal..
2015 Cardiome Pharma reports Q3 results


Comments 
Advertisement
Chart CARDIOME PHARMA CORP
Duration : Period :
Cardiome Pharma Corp Technical Analysis Chart | COM | CA14159U3010 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions